Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Bezlotoxumab
Medication labelZINPLAVA™ is indicated to reduce recurrence of Clostridioides difficile infection (CDI) in adults and pediatric patients 1 year of age and…
Why this: Advisory · dailymed-prescription
ZINPLAVA™ is indicated to reduce recurrence of Clostridioides difficile infection (CDI) in adults and pediatric patients 1 year of age and older who are receiving antibacterial drug treatment for CDI and are at a high risk for CDI recurrence. Limitation of Use: ZINPLAVA is not indicated for the treatment of CDI. ZINPLAVA is not an antibacterial drug. ZINPLAVA should only be used in conjunction with antibacterial drug treatment of CDI. [See Dosage and Administration (2.1).]
- generic_name
- bezlotoxumab
- product_names
- bezlotoxumab
- ndc
- 0006-3025, 0006-3025-01, 0006-3025-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en